Hillenbrand Schedules Third Quarter 2021 Earnings Call for August 5, 2021
Get Alerts HI Hot Sheet
Join SI Premium – FREE
BATESVILLE, Ind., July 21, 2021 /PRNewswire/ -- Hillenbrand, Inc. (NYSE: HI) will hold a conference call and simultaneous webcast Thursday, August 5, 2021, at 8:00 a.m. ET. They will discuss the results for the third quarter of fiscal year 2021, which ended June 30, 2021. The live webcast, including a slide presentation, will be available at http://ir.hillenbrand.com under the "News & Events" tab and will be archived on the company's investor relations website through Friday, September 3, 2021.
To access the conference call, listeners in the United States and Canada may dial +1 (877) 407-8012, and international callers may dial +1 (412) 902-1013. Please use conference call ID number 13721745 A replay of the call will be available until midnight ET, Thursday, August 19, 2021, by dialing +1 (877) 660-6853 toll free in the United States and Canada or +1 (201) 612-7415 internationally and using the conference ID number 13721745.
Hillenbrand will issue a press release reporting its results after the market closes on Wednesday, August 4, 2021. The full text of the release and financials will be available at http://ir.hillenbrand.com.
About Hillenbrand
Hillenbrand (www.Hillenbrand.com) is a global diversified industrial company with businesses that serve a wide variety of industries around the world. We pursue profitable growth and robust cash generation to drive increased value for our shareholders. Hillenbrand's portfolio includes industrial businesses such as Coperion, Milacron Injection Molding & Extrusion, and Mold-Masters, in addition to Batesville, a recognized leader in the death care industry in North America. Hillenbrand is publicly traded on the NYSE under "HI."
View original content to download multimedia:https://www.prnewswire.com/news-releases/hillenbrand-schedules-third-quarter-2021-earnings-call-for-august-5-2021-301338927.html
SOURCE Hillenbrand, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gilead Sciences (GILD) Misses Q1 EPS by 288c
- Internationally Renowned Botulinum Toxin Experts Join WizMedi Bio's New Botulinum Toxin Development Project
- Umicore update on trading conditions over the first quarter of 2024
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!